If future studies confirm the relationship between PSMA expression and tumor angiogenesis, PET imaging with [68Ga]Ga-PSMA-HBED-CC could be explored for predicting and monitoring responses to antiangiogenic treatment in patients with breast cancer. The gene discussed is FOLH1; the disease is breast cancer.